Danger: The old boss-- same as the new boss.
It's weird that Trump would nominate both Nesheiwat for SG and Bhattacharya for NIH, people who are at opposite ends of the Pfizer pfellation spectrum.
I just don't know how to interpret that contradiction.
It's weird that Trump would nominate both Nesheiwat for SG and Bhattacharya for NIH, people who are at opposite ends of the Pfizer pfellation spectrum.
I just don't know how to interpret that contradiction.